Matches in Nanopublications for { ?s ?p "[Disruption of intracellular Notch signaling, either genetically by RNA interference targeting NOTCH1 or pharmacologically by means of the gamma-secretase inhibitor GSI-18, was used for assessing requirement of Notch signaling in pancreatic cancer initiation and maintenance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP775325.RAuJxwDlmkJAZsu_XhcudV-HtXR8NV-u4c31ZgCBEBN6E130_assertion description "[Disruption of intracellular Notch signaling, either genetically by RNA interference targeting NOTCH1 or pharmacologically by means of the gamma-secretase inhibitor GSI-18, was used for assessing requirement of Notch signaling in pancreatic cancer initiation and maintenance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP775325.RAuJxwDlmkJAZsu_XhcudV-HtXR8NV-u4c31ZgCBEBN6E130_provenance.
- NP748243.RAKpuDVnYf8NFJ9DpicfZzY3NMibWllkdr49VUtSYeiRU130_assertion description "[Disruption of intracellular Notch signaling, either genetically by RNA interference targeting NOTCH1 or pharmacologically by means of the gamma-secretase inhibitor GSI-18, was used for assessing requirement of Notch signaling in pancreatic cancer initiation and maintenance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP748243.RAKpuDVnYf8NFJ9DpicfZzY3NMibWllkdr49VUtSYeiRU130_provenance.